CASH FLOWS FROM OPERATING ACTIVITIES: | |
Net income | 9.1M |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | |
Depreciation and amortization | |
Investment impairment charges | |
Net gain on maturities and settlements of investments | |
Net amortization of investment premiums and discounts | |
Asset impairments and net losses upon disposal | |
Provision for deferred income taxes | |
Signing bonus amortization | |
Signing bonus payments | |
Loss on debt extinguishment | |
Amortization of debt discount and deferred financing costs | 2.5M |
Provision for uncollectible receivables | |
Non-cash compensation and pension expense | 18.7M |
Other non-cash items, net | -500K |
Changes in foreign currency translation adjustments | |
Change in other assets | 2.7M |
Change in accounts payable and other liabilities | -32M |
Total adjustments | |
Change in cash and cash equivalents (substantially restricted) | |
Change in trading investments and related put options (substantially restricted) | |
Change in receivables (substantially restricted) | |
Change in payment service obligations | |
Net cash provided by (used in) operating activities | 84.5M |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
Proceeds from maturities of investments classified as available-for-sale (substantially restricted) | |
Proceeds from settlement of investments | |
Purchases of short-term investments (substantially restricted) | |
Proceeds from maturities of short-term investments (substantially restricted) | |
Purchases of property and equipment | -60.4M |
Cash paid for acquisitions, net of cash acquired | |
Net cash (used in) provided by investing activities | -60.4M |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
Proceeds from issuance of debt | |
Transaction costs for issuance and amendment of debt | |
Payments on debt | |
Additional consideration issued in connection with conversion of mezzanine equity | |
Transaction costs for the conversion and issuance of stock | |
Cash dividends paid on mezzanine equity | |
Proceeds from exercise of stock options | |
Net cash used in financing activities | -15.5M |
NET CHANGE IN CASH AND CASH EQUIVALENTS | 8.6M |
CASH AND CASH EQUIVALENTS - Beginning of period | 164.5M |
CASH AND CASH EQUIVALENTS - End of period | 173.1M |